Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Economy

Dr. Jan Adams named Chief Commercial Officer at Grünenthal

by
September 30, 2024
in Economy, Investing
0
Dr. Jan Adams named Chief Commercial Officer at Grünenthal
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Aachen, Germany – Global pharmaceutical company Grünenthal announced today that Jan Adams, M.D., currently Chief Scientific Officer (CSO) and member of the Corporate Executive Board, will be taking on the role of Chief Commercial Officer (CCO) effective October 1st, 2024.

Adams has over two decades of experience in the pharmaceutical and healthcare industry. Since joining Grünenthal in 2017, he has been instrumental in driving the company’s transformational journey. As CSO, he has successfully led the development of a state-of-the-art R&D organization and redefined the company’s R&D strategy. Under his leadership, Grünenthal has also built an industry-leading pipeline focused on delivering innovative treatments for acute and chronic pain. Prior to his role as CSO, Adams served as Head of Strategy and Portfolio, where he played a key role in several successful M&A projects and Grünenthal’s entry into the U.S. market. Before joining Grünenthal, he held positions at Takeda, McKinsey & Company, and Novartis. Adams began his career as a resident in cardiology and holds a Medical Doctor degree. He is married and has two children.

Adams will be succeeding Janneke van der Kamp, who will be leaving Grünenthal to pursue an opportunity outside of the company.

Grünenthal is a global leader in pain management and related diseases. The company is known for its science-based and fully integrated approach to developing innovative treatments and state-of-the-art technologies for patients worldwide. Their mission is to change lives for the better, with a focus on innovation. Grünenthal operates in 27 countries across Europe, Latin America, and the U.S. and has products available in approximately 100 countries. As of 2023, the company had around 4,400 employees and achieved revenues of €1.8 billion.

For more information about Grünenthal, please visit their website at https://www.grunenthal.com.

Follow Grünenthal on LinkedIn at Grunenthal Group and on Instagram at grunenthal.

For media inquiries, please contact Florian Dieckmann, Head of Global Corporate Affairs & Communication, at +49 241 569-2555 or via email at Florian.dieckmann@grunenthal.com.

This news was distributed by https://pressat.co.uk/.

ShareTweetPin

Related Posts

Tech 5: OpenAI/Microsoft Talks Get Tense, SoftBank Floats Arizona Robotics Hub
Investing

Tech 5: OpenAI/Microsoft Talks Get Tense, SoftBank Floats Arizona Robotics Hub

June 22, 2025
Editor’s Picks: Silver Price Hits 13 Year High, Gold Takes a Breather
Investing

Editor’s Picks: Silver Price Hits 13 Year High, Gold Takes a Breather

June 22, 2025
Crypto Market Recap: Bitcoin Price Stalls as Fed Holds Rates Steady, Circle Shares Jump
Investing

Crypto Market Recap: Bitcoin Price Stalls as Fed Holds Rates Steady, Circle Shares Jump

June 21, 2025
Top 5 Canadian Mining Stocks This Week: Royalties Inc. Jumps 183 Percent on Legal Win
Investing

Top 5 Canadian Mining Stocks This Week: Royalties Inc. Jumps 183 Percent on Legal Win

June 21, 2025
Critical Metals Secures US$120 Million Loan LOI for Tanbreez Rare Earths Project
Investing

Critical Metals Secures US$120 Million Loan LOI for Tanbreez Rare Earths Project

June 20, 2025
Mali Court Seizes Control of Barrick Gold Mine Amid Escalating Dispute
Investing

Mali Court Seizes Control of Barrick Gold Mine Amid Escalating Dispute

June 20, 2025
Next Post
Revised 2023 UK economic growth figures show significant improvement, but challenges remain

Revised 2023 UK economic growth figures show significant improvement, but challenges remain

Recommended

Meralco plans new substations at Ayala Land sites

Meralco plans new substations at Ayala Land sites

August 6, 2024
David Morgan: Silver Squeeze 2.0 — Will Price Run on March 31?

David Morgan: Silver Squeeze 2.0 — Will Price Run on March 31?

March 31, 2025
Recruiting 5,000 new HMRC compliance officers just first step in fixing UK’s tax system, says Blick Rothenberg

Recruiting 5,000 new HMRC compliance officers just first step in fixing UK’s tax system, says Blick Rothenberg

October 6, 2024
Gov’t fully awards bond offer as yields drop on rate cut bets

Gov’t fully awards bond offer as yields drop on rate cut bets

October 1, 2024
Two more tropical cyclones are likely to form as Enteng exited PAR- PAGASA

Two more tropical cyclones are likely to form as Enteng exited PAR- PAGASA

September 4, 2024
Editor’s Picks: Gold Hits New High, Silver Squeeze 2.0 Next Week?

Editor’s Picks: Gold Hits New High, Silver Squeeze 2.0 Next Week?

March 29, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Thank you

    Copyright © 2025 investdailypro.com | All Rights Reserved